Respiratory - European Medical Journal

Continue

Respiratory

Filter
25 Jul 2017

ANTABIO Awarded Up to $8.9M from CARB-X to Accelerate the Development of Its New Treatment For Chronic Infections in Cystic Fibrosis Patients

Labège, France, 25 July, 2017 – Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs…
30 May 2017

No Association Between Low Vitamin D and Increased Asthma Risk

A NEW study focussing on the analysis of genetic data was recently conducted to determine whether previous observational studies correlating low levels…
15 May 2017

Enzyme Offers New Treatment for Inflammatory Lung Disease

CHITIN, a compound known for its strength, can be destroyed by an enzyme secreted by the lungs according to results from a recent study. When…
15 May 2017

Development of Allergic Asthma Prevented by Chloroquine and Quinine

KEY symptoms of asthma may be treatable, according to the results of a study investigating the effects of chloroquine and quinine in mice models of…
9 May 2017

Introducing EMJ Urology 5.1

United Kingdom, May 09, 2017: Welcome to the newest edition of our EMJ Urology eJournal, packed with the latest urological developments. This issue is…
5 May 2017

Relvar Ellipta Significantly Improved Asthma Control in Salford Lung Study Patients Compared with Their Usual Care

GlaxoSmithKline plc and Innoviva Inc today announced positive results from the innovative Salford Lung Study (SLS) in asthma.
5 May 2017

Osimertinib Improves Symptoms in Advanced Lung Cancer Patients

Osimertinib improves cancer-related symptoms in patients with advanced lung cancer, according to an analysis presented at the ELCC.
5 May 2017

White Blood Cell Count Predicts Response to Lung Cancer Immunotherapy

Geneva, Switzerland, 05 May 2017 – White blood cell counts can predict whether or not lung cancer patients will benefit from immunotherapy, according to…
We’ve noticed you’re accessing
from North/South America.